# 3 More Businesses Could Start Growing, Selling Medical Cannabis as DPS Expands > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/texas-compassionate-use-program-expansion/ > **Published:** 2026-04-03T02:02:43-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:31:24-04:00 > **Clinical Summary:** Texas Compassionate Use Program expansion adds licensed medical cannabis operators, improving patient access to low-THC cannabis products. --- ✦ New CED Clinical Relevance  #76Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic AccessLow-Thc[State Policy](https://cedclinic.com/will-the-coronavirus-force-states-to-legalize-marijuana/)EpilepsyPtsd Why This Matters Texas’s expansion of licensed medical cannabis operators represents a significant access improvement for patients in one of the most restrictive medical cannabis programs in the US. This development may reduce geographic barriers and wait times that have historically limited patient access to low-THC cannabis products. Clinical Summary The Texas Department of Public Safety is licensing three additional medical cannabis operators under the state’s Compassionate Use Program, which currently allows only low-THC cannabis products (≤1% THC by weight) for specific qualifying conditions including epilepsy, PTSD, cancer, and autism. Texas previously operated with only three licensed dispensing organizations statewide, creating significant access challenges for patients across the state’s vast geography. The expansion aims to improve product availability and reduce patient travel burden. Dr. Caplan’s Take “While this expansion is meaningful for Texas patients, the program remains severely limited compared to other states—both in THC content and qualifying conditions. The real clinical impact will depend on whether these new operators can meaningfully reduce the current supply shortages and geographic access barriers.” Clinical Perspective 🧠 Clinicians treating qualifying patients should monitor whether this expansion translates to improved product availability and reduced costs in their region. Patients may benefit from reduced travel distances, but the fundamental limitations of Texas’s program—restricted THC levels and limited condition list—remain unchanged. This may serve as a pilot for further program expansion. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%203%20more%20businesses%20could%20start%20growing%2C%20selling%20medical%20cannabis%20as%20DPS%20expands%20....%20%40drcaplan&url=https%3A//www.kxan.com/news/texas/3-more-businesses-could-start-growing-selling-medical-cannabis-as-dps-expands-compassionate-use/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.kxan.com/news/texas/3-more-businesses-could-start-growing-selling-medical-cannabis-as-dps-expands-compassionate-use/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%203%20more%20businesses%20could%20start%20growing%2C%20selling%20medical%20cannabis%20as%20DPS%20expands%20....%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.kxan.com/news/texas/3-more-businesses-could-start-growing-selling-medical-cannabis-as-dps-expands-compassionate-use/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.kxan.com/news/texas/3-more-businesses-could-start-growing-selling-medical-cannabis-as-dps-expands-compassionate-use/](https://www.kxan.com/news/texas/3-more-businesses-could-start-growing-selling-medical-cannabis-as-dps-expands-compassionate-use/) Table of Contents - [FAQ](#FAQ)[What type of clinical relevance does this have?](#What_type_of_clinical_relevance_does_this_have) - [What medical conditions are addressed in this cannabis news?](#What_medical_conditions_are_addressed_in_this_cannabis_news) - [What type of cannabis policy is being discussed?](#What_type_of_cannabis_policy_is_being_discussed) - [Is this about recreational or medical cannabis?](#Is_this_about_recreational_or_medical_cannabis) - [How significant are these policy developments?](#How_significant_are_these_policy_developments) - [Related](#Related) ## FAQ #### What type of clinical relevance does this have? This article has “Notable Clinical Interest” classification (#76). It represents emerging findings or policy developments that are worth monitoring closely by healthcare professionals. #### What medical conditions are addressed in this cannabis news? Based on the tags shown, this article specifically addresses [epilepsy treatment](https://cedclinic.com/cannabidiol-for-epilepsy-treatment-rare-forms/). The focus appears to be on low-THC cannabis products for [epilepsy management](https://cedclinic.com/cannabinoid-like-compound-seizure-reduction/). #### What type of cannabis policy is being discussed? This appears to involve state-level policy changes regarding cannabis access. The policy specifically relates to low-THC cannabis products, which are often regulated differently than full-spectrum cannabis. #### Is this about recreational or medical cannabis? This is focused on medical cannabis, specifically low-THC products for [epilepsy treatment](https://cedclinic.com/cannabidiol-for-epilepsy-treatment-rare-forms/). The clinical relevance classification and epilepsy tag indicate this is medical rather than recreational cannabis policy. #### How significant are these policy developments? The developments are considered noteworthy enough to warrant close monitoring by clinicians. While not groundbreaking, they represent important emerging changes in cannabis access policy that could impact patient care. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “3 more businesses could start growing, selling medical cannabis as DPS expands … – KXAN Austin”, “url”: “https://www.kxan.com/news/texas/3-more-businesses-could-start-growing-selling-medical-cannabis-as-dps-expands-compassionate-use/”, “datePublished”: “2026-04-02T22:44:21Z”, “about”: “3 more businesses could start growing”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Medical cannabis expected in Montgomery next month – WSFA](https://cedclinic.com/alabama-medical-cannabis-geographic-expansion-montgomery/) Learn about the upcoming availability of medical cannabis in Montgomery and its potential impact on patient access. [Read More](https://cedclinic.com/alabama-medical-cannabis-geographic-expansion-montgomery/) [New Clinical Insights on Cannabis and Patient Outcomes](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) Explore recent clinical findings on cannabis and how they influence patient treatment outcomes. [Explore Insights](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) [Georgia lawmakers approve changes to expand medical cannabis bill – WSB Radio](https://cedclinic.com/georgia-medical-cannabis-access-barriers-thc-cap-removal/) Review legislative changes in Georgia aimed at expanding [medical cannabis access](https://cedclinic.com/medical-marijuana-card-reciprocity/) and their implications. [Learn More](https://cedclinic.com/georgia-medical-cannabis-access-barriers-thc-cap-removal/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).